Literature DB >> 15136699

EEG abnormalities in frontotemporal lobar degeneration.

D Chan1, R J Walters, E L Sampson, J M Schott, S J Smith, M N Rossor.   

Abstract

The EEG appearances in patients with frontotemporal lobar degeneration (FTLD) were compared with those in patients with Alzheimer disease (AD). EEG abnormalities were found in 61% of FTLD patients, with the degree of EEG abnormality increasing with dementia severity. There was no significant difference in the severity of EEG abnormality between the FTLD and AD patient groups. These data suggest a need for reappraisal of the role of the EEG in the diagnostic differentiation of FTLD from AD.

Entities:  

Mesh:

Year:  2004        PMID: 15136699     DOI: 10.1212/01.wnl.0000123103.89419.b7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  EEG in neurological conditions other than epilepsy: when does it help, what does it add?

Authors:  S J M Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

Review 2.  The diagnostic utility of EEG in early-onset dementia: a systematic review of the literature with narrative analysis.

Authors:  Christina Micanovic; Suvankar Pal
Journal:  J Neural Transm (Vienna)       Date:  2013-07-31       Impact factor: 3.575

Review 3.  The diagnosis of young-onset dementia.

Authors:  Martin N Rossor; Nick C Fox; Catherine J Mummery; Jonathan M Schott; Jason D Warren
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

Review 4.  Frontotemporal lobar degeneration.

Authors:  Keith A Josephs
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 5.  Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.

Authors:  Barbara Borroni; Alberto Benussi; Enrico Premi; Antonella Alberici; Elena Marcello; Fabrizio Gardoni; Monica Di Luca; Alessandro Padovani
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype.

Authors:  Saber Sami; Nitin Williams; Laura E Hughes; Thomas E Cope; Timothy Rittman; Ian T S Coyle-Gilchrist; Richard N Henson; James B Rowe
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

Review 7.  Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach.

Authors:  Andras Attila Horvath; Emoke Anna Csernus; Sara Lality; Rafal M Kaminski; Anita Kamondi
Journal:  Front Neurosci       Date:  2020-10-15       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.